Sign in

CIK 0000944809

  • Accelerated filer

OPKO HEALTH, INC.

Sign in to watch
Ticker
OPK
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
752402409
Phone
+1 305-575-4181
Business address
4400 BISCAYNE BLVD., MIAMI, FL, 33137
Former names
EXEGENICS INC, eXegenics Inc, CYTOCLONAL PHARMACEUTICS INC /DE
  1. 4 Open-market buy CEO & Chairman bought 100,000 shares at an average $3.46 ($346,443)
  2. 4 Open-market buy CEO & Chairman bought 100,000 shares at an average $3.69 ($368,987)
  3. 4 Open-market buy Vice Chairman & CTO bought 10 shares at $3.73 ($37)
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Open-market buy CEO & Chairman bought 200,000 shares at an average $3.62 ($723,927)
  13. 4 Open-market buy SVP OPKO; Exec Chairman BRLI bought 50,000 shares at $3.81 ($190,500)
  14. 4 Open-market buy CEO & Chairman bought 400,000 shares at an average $3.64 ($1,455,972)
  15. 4 Open-market buy CEO & Chairman bought 75,000 shares at an average $3.65 ($273,745)
  16. 4 Open-market buy CEO & Chairman bought 75,000 shares at an average $3.84 ($287,743)
  17. 4 Open-market buy CEO & Chairman bought 25,000 shares at an average $3.91 ($97,783)
  18. 4 Open-market buy CEO & Chairman bought 25,000 shares at an average $3.94 ($98,481)
  19. 4 Open-market buy CEO & Chairman bought 300,000 shares at an average $3.91 ($1,173,841)
  20. 4 Derivatives Options or other derivatives

Page 10 of 106 · 2,118 filings